Cetero Research Adds DGD Research, Enhancing Their Therapeutic Capabilities and Expertise to Include Endocrinology and Metabolic Disorders

CARY, N.C.--(BUSINESS WIRE)--Cetero Research, the world's largest provider of early clinical and bioanalytical research services for the pharmaceutical industry, has enhanced their therapeutic research capabilities and expertise with the addition of DGD Research (formerly Diabetes & Glandular Disease Research Associates), a San Antonio, TX-based, contract research organization.
MORE ON THIS TOPIC